nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—Mecp2 and Associated Rett Syndrome—POU4F1—glaucoma	0.0294	0.0911	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—ATOH7—glaucoma	0.0216	0.0669	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.0178	0.055	CbGpPWpGaD
Cysteamine—SST—Mecp2 and Associated Rett Syndrome—BDNF—glaucoma	0.00875	0.0271	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—OPN4—glaucoma	0.00861	0.0266	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00771	0.0238	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00705	0.0218	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CA1—glaucoma	0.00668	0.0207	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00638	0.0197	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00635	0.0196	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.0063	0.0195	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00604	0.0187	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00567	0.0175	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00544	0.0168	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—OPN4—glaucoma	0.0048	0.0148	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—OPN4—glaucoma	0.0046	0.0142	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00457	0.0141	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—PTGFR—glaucoma	0.00432	0.0134	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—TXN—glaucoma	0.00415	0.0128	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—PTGFR—glaucoma	0.00414	0.0128	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—ABCA1—glaucoma	0.00396	0.0123	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—SOD1—glaucoma	0.00353	0.0109	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00341	0.0105	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00327	0.0101	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—ABCA1—glaucoma	0.00322	0.00997	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—NGFR—glaucoma	0.00307	0.00948	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—NGF—glaucoma	0.00302	0.00935	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00301	0.00931	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—NTRK1—glaucoma	0.00291	0.00901	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—SOD1—glaucoma	0.00287	0.00889	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—EDN1—glaucoma	0.00281	0.00869	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—MTHFR—glaucoma	0.0028	0.00866	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—OPN4—glaucoma	0.00271	0.00838	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—EDN1—glaucoma	0.00269	0.00834	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—APOE—glaucoma	0.00261	0.00806	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—OPN4—glaucoma	0.0026	0.00804	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—ABCA1—glaucoma	0.00256	0.00792	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—OPN4—glaucoma	0.00246	0.00761	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—C3—glaucoma	0.00246	0.0076	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PTGFR—glaucoma	0.00244	0.00755	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—OPN4—glaucoma	0.00236	0.0073	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—C3—glaucoma	0.00235	0.00728	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PTGFR—glaucoma	0.00234	0.00724	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—FAS—glaucoma	0.00228	0.00706	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—SOD1—glaucoma	0.00228	0.00706	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—MTHFR—glaucoma	0.00228	0.00705	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PTGFR—glaucoma	0.00222	0.00686	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—SMO—glaucoma	0.00218	0.00674	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—GSTM1—glaucoma	0.00213	0.00657	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PTGFR—glaucoma	0.00212	0.00657	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LRP12—glaucoma	0.0021	0.00649	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—SMO—glaucoma	0.00209	0.00646	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—C3—glaucoma	0.00207	0.00641	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LRP12—glaucoma	0.00201	0.00622	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—C3—glaucoma	0.00199	0.00614	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00189	0.00583	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—MTHFR—glaucoma	0.00181	0.0056	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00181	0.00559	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00165	0.00509	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00158	0.00488	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—glaucoma	0.00156	0.00482	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—OPN4—glaucoma	0.00145	0.0045	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.00144	0.00447	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—EDN1—glaucoma	0.00144	0.00444	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—OPN4—glaucoma	0.00139	0.00431	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—EDN1—glaucoma	0.00138	0.00426	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HEYL—glaucoma	0.00135	0.00418	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTGFR—glaucoma	0.00131	0.00405	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HEYL—glaucoma	0.0013	0.00401	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CDKN2A—glaucoma	0.00128	0.00396	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTGFR—glaucoma	0.00126	0.00388	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—C3—glaucoma	0.00125	0.00388	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—glaucoma	0.00124	0.00383	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—glaucoma	0.00121	0.00373	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—C3—glaucoma	0.0012	0.00372	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—PTGS2—glaucoma	0.0012	0.00371	CbGpPWpGaD
Cysteamine—Dermatitis—Carbachol—glaucoma	0.00116	0.00171	CcSEcCtD
Cysteamine—Fatigue—Apraclonidine—glaucoma	0.00116	0.00171	CcSEcCtD
Cysteamine—Somnolence—Bimatoprost—glaucoma	0.00116	0.00171	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—PTGS2—glaucoma	0.00115	0.00357	CbGpPWpGaD
Cysteamine—Headache—Carbachol—glaucoma	0.00115	0.0017	CcSEcCtD
Cysteamine—Constipation—Apraclonidine—glaucoma	0.00115	0.00169	CcSEcCtD
Cysteamine—Dyspepsia—Bimatoprost—glaucoma	0.00114	0.00169	CcSEcCtD
Cysteamine—Hypertension—Brinzolamide—glaucoma	0.00114	0.00169	CcSEcCtD
Cysteamine—Leukopenia—Pilocarpine—glaucoma	0.00114	0.00168	CcSEcCtD
Cysteamine—Mood swings—Timolol—glaucoma	0.00114	0.00168	CcSEcCtD
Cysteamine—Nausea—Carteolol—glaucoma	0.00114	0.00168	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—CDKN1B—glaucoma	0.00113	0.00351	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00113	0.00167	CcSEcCtD
Cysteamine—Headache—Levobunolol—glaucoma	0.00113	0.00167	CcSEcCtD
Cysteamine—Discomfort—Dorzolamide—glaucoma	0.00113	0.00167	CcSEcCtD
Cysteamine—Nervous system disorder—Brimonidine—glaucoma	0.00113	0.00167	CcSEcCtD
Cysteamine—Discomfort—Travoprost—glaucoma	0.00113	0.00167	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00112	0.00166	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00112	0.00165	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—SMO—glaucoma	0.00112	0.00346	CbGpPWpGaD
Cysteamine—Skin disorder—Brimonidine—glaucoma	0.00112	0.00165	CcSEcCtD
Cysteamine—Nausea—Diclofenamide—glaucoma	0.00112	0.00165	CcSEcCtD
Cysteamine—Discomfort—Brinzolamide—glaucoma	0.00111	0.00165	CcSEcCtD
Cysteamine—Dizziness—Latanoprost—glaucoma	0.00111	0.00164	CcSEcCtD
Cysteamine—Confusional state—Dorzolamide—glaucoma	0.00111	0.00164	CcSEcCtD
Cysteamine—Liver function test abnormal—Timolol—glaucoma	0.00111	0.00164	CcSEcCtD
Cysteamine—Feeling abnormal—Apraclonidine—glaucoma	0.0011	0.00163	CcSEcCtD
Cysteamine—Vomiting—Methazolamide—glaucoma	0.0011	0.00163	CcSEcCtD
Cysteamine—Anaphylactic shock—Dorzolamide—glaucoma	0.0011	0.00162	CcSEcCtD
Cysteamine—Hypertension—Pilocarpine—glaucoma	0.0011	0.00162	CcSEcCtD
Cysteamine—Gastrointestinal pain—Apraclonidine—glaucoma	0.0011	0.00162	CcSEcCtD
Cysteamine—Rash—Methazolamide—glaucoma	0.00109	0.00161	CcSEcCtD
Cysteamine—Dermatitis—Methazolamide—glaucoma	0.00109	0.00161	CcSEcCtD
Cysteamine—Nausea—Carbachol—glaucoma	0.00109	0.00161	CcSEcCtD
Cysteamine—Headache—Methazolamide—glaucoma	0.00108	0.0016	CcSEcCtD
Cysteamine—Nausea—Levobunolol—glaucoma	0.00107	0.00159	CcSEcCtD
Cysteamine—Nervous system disorder—Travoprost—glaucoma	0.00107	0.00159	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—SMO—glaucoma	0.00107	0.00331	CbGpPWpGaD
Cysteamine—Discomfort—Pilocarpine—glaucoma	0.00107	0.00158	CcSEcCtD
Cysteamine—Somnolence—Acetazolamide—glaucoma	0.00107	0.00157	CcSEcCtD
Cysteamine—Skin disorder—Travoprost—glaucoma	0.00106	0.00157	CcSEcCtD
Cysteamine—Abdominal pain—Apraclonidine—glaucoma	0.00106	0.00157	CcSEcCtD
Cysteamine—Nervous system disorder—Brinzolamide—glaucoma	0.00106	0.00157	CcSEcCtD
Cysteamine—Rash—Latanoprost—glaucoma	0.00106	0.00156	CcSEcCtD
Cysteamine—Dermatitis—Latanoprost—glaucoma	0.00106	0.00156	CcSEcCtD
Cysteamine—Dyspepsia—Acetazolamide—glaucoma	0.00106	0.00156	CcSEcCtD
Cysteamine—Headache—Latanoprost—glaucoma	0.00105	0.00155	CcSEcCtD
Cysteamine—Skin disorder—Brinzolamide—glaucoma	0.00105	0.00155	CcSEcCtD
Cysteamine—Anorexia—Dorzolamide—glaucoma	0.00105	0.00155	CcSEcCtD
Cysteamine—Confusional state—Pilocarpine—glaucoma	0.00105	0.00155	CcSEcCtD
Cysteamine—Decreased appetite—Acetazolamide—glaucoma	0.00104	0.00154	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00103	0.00153	CcSEcCtD
Cysteamine—Fatigue—Acetazolamide—glaucoma	0.00103	0.00153	CcSEcCtD
Cysteamine—Nausea—Methazolamide—glaucoma	0.00103	0.00152	CcSEcCtD
Cysteamine—SST—Signaling Pathways—RPTOR—glaucoma	0.00102	0.00317	CbGpPWpGaD
Cysteamine—Somnolence—Brimonidine—glaucoma	0.00102	0.00151	CcSEcCtD
Cysteamine—Mental disorder—Clonidine—glaucoma	0.00102	0.00151	CcSEcCtD
Cysteamine—Erythema—Clonidine—glaucoma	0.00102	0.0015	CcSEcCtD
Cysteamine—Dyspepsia—Brimonidine—glaucoma	0.00101	0.0015	CcSEcCtD
Cysteamine—Hallucination—Betaxolol—glaucoma	0.00101	0.00149	CcSEcCtD
Cysteamine—Tension—Clonidine—glaucoma	0.000997	0.00147	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000993	0.00147	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NCK2—glaucoma	0.000992	0.00307	CbGpPWpGaD
Cysteamine—Fatigue—Brimonidine—glaucoma	0.000992	0.00147	CcSEcCtD
Cysteamine—Anorexia—Pilocarpine—glaucoma	0.00099	0.00146	CcSEcCtD
Cysteamine—Feeling abnormal—Acetazolamide—glaucoma	0.000988	0.00146	CcSEcCtD
Cysteamine—Hypersensitivity—Apraclonidine—glaucoma	0.000987	0.00146	CcSEcCtD
Cysteamine—Nervousness—Clonidine—glaucoma	0.000987	0.00146	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—RPTOR—glaucoma	0.000982	0.00304	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—glaucoma	0.000981	0.00303	CbGpPWpGaD
Cysteamine—Somnolence—Dorzolamide—glaucoma	0.000977	0.00144	CcSEcCtD
Cysteamine—Dyspepsia—Dorzolamide—glaucoma	0.000967	0.00143	CcSEcCtD
Cysteamine—Dyspepsia—Travoprost—glaucoma	0.000963	0.00142	CcSEcCtD
Cysteamine—Asthenia—Apraclonidine—glaucoma	0.000961	0.00142	CcSEcCtD
Cysteamine—Somnolence—Brinzolamide—glaucoma	0.00096	0.00142	CcSEcCtD
Cysteamine—Decreased appetite—Dorzolamide—glaucoma	0.000955	0.00141	CcSEcCtD
Cysteamine—Urticaria—Acetazolamide—glaucoma	0.000952	0.00141	CcSEcCtD
Cysteamine—Tremor—Clonidine—glaucoma	0.000952	0.00141	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NCK2—glaucoma	0.000951	0.00294	CbGpPWpGaD
Cysteamine—Dyspepsia—Brinzolamide—glaucoma	0.000951	0.00141	CcSEcCtD
Cysteamine—Body temperature increased—Acetazolamide—glaucoma	0.000948	0.0014	CcSEcCtD
Cysteamine—Fatigue—Dorzolamide—glaucoma	0.000947	0.0014	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Travoprost—glaucoma	0.000944	0.0014	CcSEcCtD
Cysteamine—Fatigue—Travoprost—glaucoma	0.000943	0.00139	CcSEcCtD
Cysteamine—Decreased appetite—Brinzolamide—glaucoma	0.000939	0.00139	CcSEcCtD
Cysteamine—Constipation—Travoprost—glaucoma	0.000935	0.00138	CcSEcCtD
Cysteamine—Agitation—Clonidine—glaucoma	0.000934	0.00138	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000933	0.00138	CcSEcCtD
Cysteamine—Asthenia—Bimatoprost—glaucoma	0.000932	0.00138	CcSEcCtD
Cysteamine—Fatigue—Brinzolamide—glaucoma	0.000931	0.00138	CcSEcCtD
Cysteamine—Somnolence—Pilocarpine—glaucoma	0.000923	0.00136	CcSEcCtD
Cysteamine—Immune system disorder—Betaxolol—glaucoma	0.000918	0.00136	CcSEcCtD
Cysteamine—Diarrhoea—Apraclonidine—glaucoma	0.000917	0.00135	CcSEcCtD
Cysteamine—Dyspepsia—Pilocarpine—glaucoma	0.000914	0.00135	CcSEcCtD
Cysteamine—Feeling abnormal—Dorzolamide—glaucoma	0.000905	0.00134	CcSEcCtD
Cysteamine—Decreased appetite—Pilocarpine—glaucoma	0.000902	0.00133	CcSEcCtD
Cysteamine—Feeling abnormal—Travoprost—glaucoma	0.000901	0.00133	CcSEcCtD
Cysteamine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000898	0.00133	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000896	0.00132	CcSEcCtD
Cysteamine—Gastrointestinal pain—Travoprost—glaucoma	0.000895	0.00132	CcSEcCtD
Cysteamine—Feeling abnormal—Brinzolamide—glaucoma	0.00089	0.00132	CcSEcCtD
Cysteamine—Mental disorder—Betaxolol—glaucoma	0.00089	0.00132	CcSEcCtD
Cysteamine—Constipation—Pilocarpine—glaucoma	0.000888	0.00131	CcSEcCtD
Cysteamine—Dizziness—Apraclonidine—glaucoma	0.000886	0.00131	CcSEcCtD
Cysteamine—Malnutrition—Betaxolol—glaucoma	0.000884	0.00131	CcSEcCtD
Cysteamine—Erythema—Betaxolol—glaucoma	0.000884	0.00131	CcSEcCtD
Cysteamine—Urticaria—Dorzolamide—glaucoma	0.000873	0.00129	CcSEcCtD
Cysteamine—Body temperature increased—Dorzolamide—glaucoma	0.000869	0.00128	CcSEcCtD
Cysteamine—Abdominal pain—Dorzolamide—glaucoma	0.000869	0.00128	CcSEcCtD
Cysteamine—Tension—Betaxolol—glaucoma	0.000868	0.00128	CcSEcCtD
Cysteamine—Abdominal pain—Travoprost—glaucoma	0.000865	0.00128	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—TP53—glaucoma	0.000865	0.00267	CbGpPWpGaD
Cysteamine—Asthenia—Acetazolamide—glaucoma	0.00086	0.00127	CcSEcCtD
Cysteamine—Dizziness—Bimatoprost—glaucoma	0.000859	0.00127	CcSEcCtD
Cysteamine—Nervousness—Betaxolol—glaucoma	0.000859	0.00127	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000859	0.00127	CcSEcCtD
Cysteamine—Urticaria—Brinzolamide—glaucoma	0.000858	0.00127	CcSEcCtD
Cysteamine—Feeling abnormal—Pilocarpine—glaucoma	0.000856	0.00126	CcSEcCtD
Cysteamine—Discomfort—Clonidine—glaucoma	0.000854	0.00126	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—glaucoma	0.000854	0.00264	CbGpPWpGaD
Cysteamine—Vomiting—Apraclonidine—glaucoma	0.000852	0.00126	CcSEcCtD
Cysteamine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000849	0.00125	CcSEcCtD
Cysteamine—Hypersensitivity—Brimonidine—glaucoma	0.000848	0.00125	CcSEcCtD
Cysteamine—Dermatitis—Apraclonidine—glaucoma	0.000844	0.00125	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HDAC9—glaucoma	0.000844	0.00261	CbGpPWpGaD
Cysteamine—Headache—Apraclonidine—glaucoma	0.000839	0.00124	CcSEcCtD
Cysteamine—Confusional state—Clonidine—glaucoma	0.000836	0.00124	CcSEcCtD
Cysteamine—Tremor—Betaxolol—glaucoma	0.000829	0.00122	CcSEcCtD
Cysteamine—Hallucination—Timolol—glaucoma	0.000826	0.00122	CcSEcCtD
Cysteamine—Asthenia—Brimonidine—glaucoma	0.000825	0.00122	CcSEcCtD
Cysteamine—Abdominal pain—Pilocarpine—glaucoma	0.000821	0.00121	CcSEcCtD
Cysteamine—Body temperature increased—Pilocarpine—glaucoma	0.000821	0.00121	CcSEcCtD
Cysteamine—Diarrhoea—Acetazolamide—glaucoma	0.00082	0.00121	CcSEcCtD
Cysteamine—Rash—Bimatoprost—glaucoma	0.000819	0.00121	CcSEcCtD
Cysteamine—Dermatitis—Bimatoprost—glaucoma	0.000818	0.00121	CcSEcCtD
Cysteamine—Anaemia—Betaxolol—glaucoma	0.000817	0.00121	CcSEcCtD
Cysteamine—Connective tissue disorder—Timolol—glaucoma	0.000816	0.00121	CcSEcCtD
Cysteamine—Headache—Bimatoprost—glaucoma	0.000814	0.0012	CcSEcCtD
Cysteamine—Nervous system disorder—Clonidine—glaucoma	0.000813	0.0012	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—EDN1—glaucoma	0.000811	0.00251	CbGpPWpGaD
Cysteamine—Hypersensitivity—Dorzolamide—glaucoma	0.000809	0.0012	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HDAC9—glaucoma	0.000809	0.0025	CbGpPWpGaD
Cysteamine—Hypersensitivity—Travoprost—glaucoma	0.000806	0.00119	CcSEcCtD
Cysteamine—Skin disorder—Clonidine—glaucoma	0.000805	0.00119	CcSEcCtD
Cysteamine—Nausea—Apraclonidine—glaucoma	0.000796	0.00118	CcSEcCtD
Cysteamine—Hypersensitivity—Brinzolamide—glaucoma	0.000796	0.00118	CcSEcCtD
Cysteamine—Dizziness—Acetazolamide—glaucoma	0.000793	0.00117	CcSEcCtD
Cysteamine—Anorexia—Clonidine—glaucoma	0.00079	0.00117	CcSEcCtD
Cysteamine—Asthenia—Dorzolamide—glaucoma	0.000788	0.00116	CcSEcCtD
Cysteamine—Asthenia—Travoprost—glaucoma	0.000785	0.00116	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—glaucoma	0.000779	0.00241	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—EDN1—glaucoma	0.000778	0.00241	CbGpPWpGaD
Cysteamine—Asthenia—Brinzolamide—glaucoma	0.000775	0.00115	CcSEcCtD
Cysteamine—Nausea—Bimatoprost—glaucoma	0.000772	0.00114	CcSEcCtD
Cysteamine—Hypersensitivity—Pilocarpine—glaucoma	0.000765	0.00113	CcSEcCtD
Cysteamine—Vomiting—Acetazolamide—glaucoma	0.000762	0.00113	CcSEcCtD
Cysteamine—Dizziness—Brimonidine—glaucoma	0.000761	0.00112	CcSEcCtD
Cysteamine—Diarrhoea—Dorzolamide—glaucoma	0.000752	0.00111	CcSEcCtD
Cysteamine—Headache—Acetazolamide—glaucoma	0.000751	0.00111	CcSEcCtD
Cysteamine—Immune system disorder—Timolol—glaucoma	0.00075	0.00111	CcSEcCtD
Cysteamine—Diarrhoea—Travoprost—glaucoma	0.000748	0.00111	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000748	0.0011	CcSEcCtD
Cysteamine—Asthenia—Pilocarpine—glaucoma	0.000745	0.0011	CcSEcCtD
Cysteamine—Discomfort—Betaxolol—glaucoma	0.000744	0.0011	CcSEcCtD
Cysteamine—Diarrhoea—Brinzolamide—glaucoma	0.000739	0.00109	CcSEcCtD
Cysteamine—Somnolence—Clonidine—glaucoma	0.000737	0.00109	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—EDN1—glaucoma	0.000737	0.00228	CbGpPWpGaD
Cysteamine—Confusional state—Betaxolol—glaucoma	0.000728	0.00108	CcSEcCtD
Cysteamine—Mental disorder—Timolol—glaucoma	0.000727	0.00107	CcSEcCtD
Cysteamine—Dizziness—Dorzolamide—glaucoma	0.000727	0.00107	CcSEcCtD
Cysteamine—Rash—Brimonidine—glaucoma	0.000725	0.00107	CcSEcCtD
Cysteamine—Dermatitis—Brimonidine—glaucoma	0.000725	0.00107	CcSEcCtD
Cysteamine—Dizziness—Travoprost—glaucoma	0.000723	0.00107	CcSEcCtD
Cysteamine—Malnutrition—Timolol—glaucoma	0.000722	0.00107	CcSEcCtD
Cysteamine—Erythema—Timolol—glaucoma	0.000722	0.00107	CcSEcCtD
Cysteamine—Headache—Brimonidine—glaucoma	0.000721	0.00107	CcSEcCtD
Cysteamine—Decreased appetite—Clonidine—glaucoma	0.000721	0.00107	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Clonidine—glaucoma	0.000716	0.00106	CcSEcCtD
Cysteamine—Fatigue—Clonidine—glaucoma	0.000715	0.00106	CcSEcCtD
Cysteamine—Dizziness—Brinzolamide—glaucoma	0.000714	0.00106	CcSEcCtD
Cysteamine—Nausea—Acetazolamide—glaucoma	0.000712	0.00105	CcSEcCtD
Cysteamine—Diarrhoea—Pilocarpine—glaucoma	0.00071	0.00105	CcSEcCtD
Cysteamine—Tension—Timolol—glaucoma	0.000709	0.00105	CcSEcCtD
Cysteamine—Constipation—Clonidine—glaucoma	0.000709	0.00105	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—C3—glaucoma	0.000709	0.00219	CbGpPWpGaD
Cysteamine—Nervous system disorder—Betaxolol—glaucoma	0.000708	0.00105	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—EDN1—glaucoma	0.000706	0.00218	CbGpPWpGaD
Cysteamine—Nervousness—Timolol—glaucoma	0.000702	0.00104	CcSEcCtD
Cysteamine—Skin disorder—Betaxolol—glaucoma	0.000701	0.00104	CcSEcCtD
Cysteamine—Vomiting—Dorzolamide—glaucoma	0.000699	0.00103	CcSEcCtD
Cysteamine—Rash—Dorzolamide—glaucoma	0.000693	0.00102	CcSEcCtD
Cysteamine—Dermatitis—Dorzolamide—glaucoma	0.000692	0.00102	CcSEcCtD
Cysteamine—Rash—Travoprost—glaucoma	0.00069	0.00102	CcSEcCtD
Cysteamine—Dermatitis—Travoprost—glaucoma	0.000689	0.00102	CcSEcCtD
Cysteamine—Headache—Dorzolamide—glaucoma	0.000688	0.00102	CcSEcCtD
Cysteamine—Anorexia—Betaxolol—glaucoma	0.000688	0.00102	CcSEcCtD
Cysteamine—Vomiting—Brinzolamide—glaucoma	0.000687	0.00101	CcSEcCtD
Cysteamine—Dizziness—Pilocarpine—glaucoma	0.000687	0.00101	CcSEcCtD
Cysteamine—Headache—Travoprost—glaucoma	0.000685	0.00101	CcSEcCtD
Cysteamine—Nausea—Brimonidine—glaucoma	0.000683	0.00101	CcSEcCtD
Cysteamine—Feeling abnormal—Clonidine—glaucoma	0.000683	0.00101	CcSEcCtD
Cysteamine—Rash—Brinzolamide—glaucoma	0.000681	0.00101	CcSEcCtD
Cysteamine—Dermatitis—Brinzolamide—glaucoma	0.00068	0.00101	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—C3—glaucoma	0.00068	0.0021	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Clonidine—glaucoma	0.000678	0.001	CcSEcCtD
Cysteamine—Headache—Brinzolamide—glaucoma	0.000677	0.001	CcSEcCtD
Cysteamine—SST—Signaling Pathways—SMO—glaucoma	0.00066	0.00204	CbGpPWpGaD
Cysteamine—Vomiting—Pilocarpine—glaucoma	0.00066	0.000975	CcSEcCtD
Cysteamine—Urticaria—Clonidine—glaucoma	0.000659	0.000973	CcSEcCtD
Cysteamine—Abdominal pain—Clonidine—glaucoma	0.000655	0.000969	CcSEcCtD
Cysteamine—Body temperature increased—Clonidine—glaucoma	0.000655	0.000969	CcSEcCtD
Cysteamine—Rash—Pilocarpine—glaucoma	0.000655	0.000967	CcSEcCtD
Cysteamine—Dermatitis—Pilocarpine—glaucoma	0.000654	0.000966	CcSEcCtD
Cysteamine—Nausea—Dorzolamide—glaucoma	0.000653	0.000964	CcSEcCtD
Cysteamine—Headache—Pilocarpine—glaucoma	0.00065	0.000961	CcSEcCtD
Cysteamine—Nausea—Travoprost—glaucoma	0.00065	0.00096	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—C3—glaucoma	0.000644	0.00199	CbGpPWpGaD
Cysteamine—Nausea—Brinzolamide—glaucoma	0.000642	0.000948	CcSEcCtD
Cysteamine—Dyspepsia—Betaxolol—glaucoma	0.000635	0.000939	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SMO—glaucoma	0.000633	0.00196	CbGpPWpGaD
Cysteamine—Decreased appetite—Betaxolol—glaucoma	0.000627	0.000927	CcSEcCtD
Cysteamine—Hypertension—Timolol—glaucoma	0.000624	0.000922	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000623	0.000921	CcSEcCtD
Cysteamine—Fatigue—Betaxolol—glaucoma	0.000622	0.00092	CcSEcCtD
Cysteamine—Constipation—Betaxolol—glaucoma	0.000617	0.000912	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—C3—glaucoma	0.000617	0.00191	CbGpPWpGaD
Cysteamine—Nausea—Pilocarpine—glaucoma	0.000617	0.000911	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000611	0.000903	CcSEcCtD
Cysteamine—Hypersensitivity—Clonidine—glaucoma	0.000611	0.000903	CcSEcCtD
Cysteamine—Discomfort—Timolol—glaucoma	0.000608	0.000898	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NTRK2—glaucoma	0.000604	0.00187	CbGpPWpGaD
Cysteamine—Asthenia—Clonidine—glaucoma	0.000595	0.000879	CcSEcCtD
Cysteamine—Feeling abnormal—Betaxolol—glaucoma	0.000595	0.000879	CcSEcCtD
Cysteamine—Confusional state—Timolol—glaucoma	0.000595	0.000879	CcSEcCtD
Cysteamine—Anaphylactic shock—Timolol—glaucoma	0.00059	0.000871	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NTRK2—glaucoma	0.000579	0.00179	CbGpPWpGaD
Cysteamine—Nervous system disorder—Timolol—glaucoma	0.000578	0.000855	CcSEcCtD
Cysteamine—Urticaria—Betaxolol—glaucoma	0.000573	0.000847	CcSEcCtD
Cysteamine—Skin disorder—Timolol—glaucoma	0.000573	0.000846	CcSEcCtD
Cysteamine—Body temperature increased—Betaxolol—glaucoma	0.000571	0.000843	CcSEcCtD
Cysteamine—Diarrhoea—Clonidine—glaucoma	0.000567	0.000838	CcSEcCtD
Cysteamine—Anorexia—Timolol—glaucoma	0.000562	0.000831	CcSEcCtD
Cysteamine—Dizziness—Clonidine—glaucoma	0.000548	0.00081	CcSEcCtD
Cysteamine—Hypersensitivity—Betaxolol—glaucoma	0.000532	0.000786	CcSEcCtD
Cysteamine—Vomiting—Clonidine—glaucoma	0.000527	0.000779	CcSEcCtD
Cysteamine—Somnolence—Timolol—glaucoma	0.000524	0.000775	CcSEcCtD
Cysteamine—Rash—Clonidine—glaucoma	0.000523	0.000772	CcSEcCtD
Cysteamine—Dermatitis—Clonidine—glaucoma	0.000522	0.000772	CcSEcCtD
Cysteamine—Headache—Clonidine—glaucoma	0.000519	0.000768	CcSEcCtD
Cysteamine—Dyspepsia—Timolol—glaucoma	0.000519	0.000767	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NGFR—glaucoma	0.000518	0.0016	CbGpPWpGaD
Cysteamine—Asthenia—Betaxolol—glaucoma	0.000518	0.000765	CcSEcCtD
Cysteamine—Decreased appetite—Timolol—glaucoma	0.000513	0.000757	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Timolol—glaucoma	0.000509	0.000752	CcSEcCtD
Cysteamine—Fatigue—Timolol—glaucoma	0.000508	0.000751	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NGFR—glaucoma	0.000497	0.00154	CbGpPWpGaD
Cysteamine—Diarrhoea—Betaxolol—glaucoma	0.000494	0.00073	CcSEcCtD
Cysteamine—Nausea—Clonidine—glaucoma	0.000492	0.000728	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NTRK1—glaucoma	0.000492	0.00152	CbGpPWpGaD
Cysteamine—Feeling abnormal—Timolol—glaucoma	0.000486	0.000718	CcSEcCtD
Cysteamine—Gastrointestinal pain—Timolol—glaucoma	0.000482	0.000713	CcSEcCtD
Cysteamine—Dizziness—Betaxolol—glaucoma	0.000477	0.000705	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NTRK1—glaucoma	0.000472	0.00146	CbGpPWpGaD
Cysteamine—Urticaria—Timolol—glaucoma	0.000468	0.000692	CcSEcCtD
Cysteamine—Body temperature increased—Timolol—glaucoma	0.000466	0.000689	CcSEcCtD
Cysteamine—Abdominal pain—Timolol—glaucoma	0.000466	0.000689	CcSEcCtD
Cysteamine—Vomiting—Betaxolol—glaucoma	0.000459	0.000678	CcSEcCtD
Cysteamine—Rash—Betaxolol—glaucoma	0.000455	0.000673	CcSEcCtD
Cysteamine—Dermatitis—Betaxolol—glaucoma	0.000455	0.000672	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CDKN2B—glaucoma	0.000454	0.0014	CbGpPWpGaD
Cysteamine—Headache—Betaxolol—glaucoma	0.000452	0.000668	CcSEcCtD
Cysteamine—SST—Signaling Pathways—EDN1—glaucoma	0.000435	0.00135	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN2B—glaucoma	0.000435	0.00135	CbGpPWpGaD
Cysteamine—Hypersensitivity—Timolol—glaucoma	0.000434	0.000642	CcSEcCtD
Cysteamine—Nausea—Betaxolol—glaucoma	0.000429	0.000634	CcSEcCtD
Cysteamine—Asthenia—Timolol—glaucoma	0.000423	0.000625	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—EDN1—glaucoma	0.000417	0.00129	CbGpPWpGaD
Cysteamine—Diarrhoea—Timolol—glaucoma	0.000403	0.000596	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NGF—glaucoma	0.0004	0.00124	CbGpPWpGaD
Cysteamine—Dizziness—Timolol—glaucoma	0.00039	0.000576	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NGF—glaucoma	0.000383	0.00119	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—C3—glaucoma	0.00038	0.00118	CbGpPWpGaD
Cysteamine—Vomiting—Timolol—glaucoma	0.000375	0.000554	CcSEcCtD
Cysteamine—Rash—Timolol—glaucoma	0.000372	0.000549	CcSEcCtD
Cysteamine—Dermatitis—Timolol—glaucoma	0.000371	0.000549	CcSEcCtD
Cysteamine—Headache—Timolol—glaucoma	0.000369	0.000546	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—C3—glaucoma	0.000365	0.00113	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOE—glaucoma	0.000354	0.00109	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CAV1—glaucoma	0.000351	0.00108	CbGpPWpGaD
Cysteamine—Nausea—Timolol—glaucoma	0.00035	0.000518	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—APOE—glaucoma	0.000339	0.00105	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CAV1—glaucoma	0.000336	0.00104	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FN1—glaucoma	0.000334	0.00103	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—BAD—glaucoma	0.00033	0.00102	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FN1—glaucoma	0.00032	0.00099	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BAD—glaucoma	0.000316	0.000978	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOS3—glaucoma	0.000265	0.00082	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOS3—glaucoma	0.000254	0.000786	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1B—glaucoma	0.00023	0.000711	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1B—glaucoma	0.00022	0.000681	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—glaucoma	0.000213	0.000658	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—glaucoma	0.000204	0.000631	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—glaucoma	0.000191	0.000591	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—glaucoma	0.000183	0.000567	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—glaucoma	0.000144	0.000447	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—glaucoma	0.000138	0.000428	CbGpPWpGaD
